Sigrun Holze
Papers
12
Total Citations
280
H-Index
6
About
Sigrun Holze is a urological surgeon and clinical researcher whose work sits at the forefront of minimally invasive prostate cancer surgery, with a particular focus on comparing robotic-assisted and laparoscopic radical prostatectomy. She is perhaps best known as a principal investigator of the landmark LAP-01 trial — the first multicentre, randomised, patient-blinded controlled trial directly comparing these two surgical approaches — whose initial results, published in 2021, have already garnered over 100 citations and reshaped how clinicians evaluate robotic surgery's incremental benefit. Her research extends well beyond operative metrics, encompassing patient-reported quality of life, continence outcomes, age-stratified recovery trajectories, and the nuanced learning curves experienced laparoscopic surgeons face when transitioning to robotic platforms. A 2023 systematic review and meta-analysis she contributed further consolidated the evidence base for this critical clinical question. More recently, Holze has expanded her scope to include novel robotic systems, cadaveric evaluation studies, and three-dimensional surgical planning for partial nephrectomy. With over 270 cumulative citations across her published work, she represents a rigorous, patient-centred voice in urological oncology — one whose evidence meaningfully informs surgical training, technology adoption, and shared decision-making for men facing prostate cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10